...

Several days later, in Shanghai, China's Magic City, at the headquarters of a certain biotechnology company, the chairman's office.

This office exudes utmost luxury—a gigantic redwood desk, a genuine leather executive chair, backed by an entire wall of a bookcase adorned with various antique replicas and corporate honor trophies. The air is filled with the mixed aroma of cigars and strong tea.

Chairman Jin Dafu, a middle-aged man with a plump build and rosy complexion, was greedily perusing the technical documents displayed on the tablet in front of him with his small squinted eyes.

It was a set of "simplified" technical documents regarding the adjuvant platform that had leaked from a giant corporation through special channels.

Opposite him sat the technical director Zhao Ming, a thirty-five or thirty-six-year-old returnee doctor wearing rimless glasses, looking rather capable. Zhao Ming had previously worked in the research and development department of the giant corporation for a few years and was lured back by Jin Dafu with a high salary and the position of technical vice president.

"Doctor Zhao," Jin Dafu put down the tablet, rubbed his plump hands, and said with barely contained excitement, "This stuff from the giant... give me the lowdown—can we really pull it off?"

Zhao Ming was internally well aware of the details of this technology—it was essentially an old adjuvant platform that the giant had evaluated and abandoned five or six years ago. Its effect could only be said to be slightly better than the most traditional aluminum adjuvant, but compared to the current mainstream oil emulsion adjuvants like GSK's AS03 and MF59, there was a noticeable performance gap.

The sole advantage might be its relatively mature production process, making cost control easier.

However, he remained outwardly calm, adjusted his glasses, and spoke in a professional tone: "President Jin, the technology itself is mature, after all, it's based on the giant's previous research. From scaling up from laboratory to production, the path is clear, and risks are controllable. In terms of effect, as the documents show, there is a distinct improvement over traditional aluminum adjuvants, enhancing antibody response. Of course,"

He shifted his tone, leaving room for flexibility,

"Compared to the current top international composite adjuvants, there may still be some gaps in stimulating cellular immunity and other aspects."

Jin Dafu didn't care about those technical details; he only absorbed the keywords "mature technology," "better than aluminum adjuvant," "cost controllable," in other words, it was a quick way to make money!

He slapped his thigh, causing his facial flesh to tremble: "Good! That's exactly what we want! Gap? What gap? This is 'independent innovation'! We're going to emphasize our 'breakthrough' and 'high cost-effectiveness' in marketing. The price must be cut down significantly—cheaper than imports! We want all of the nation's people to use our domestically produced, affordable, and effective adjuvant."

It was as if he could already see the product launch, orders pouring in, and stock prices soaring, as he excitedly paced around the office.

"By the way," Jin Dafu suddenly stopped, as if remembering something, and turned to Zhao Ming, "I think you mentioned a team in our country working on a new adjuvant? Led by a Professor Yang?"

Zhao Ming nodded, his tone indifferent: "Yes, President Jin. It's Professor Yang Ping's team from Sanbo Research Institute. Professor Yang is a Nobel Prize winner; their technical route is very cutting-edge, based on synthetic biology and protein de novo design, with grand ideas but also extremely complex and high-risk."

"Cutting-edge? Grand?" Jin Dafu sneered, his face full of the shrewdness and disdain particular to business people, "Isn't that just something with no substance yet? Researchers just love to dabble in these hollow concepts—ignoring available technology to painstakingly work on this stuff. Isn't it asking for trouble?"

Jin Dafu sat back in his spacious and comfortable executive chair, enjoying the moment: "Doctor Zhao, did you just say Professor Yang is a Nobel Prize winner?"

"Yes!" Zhao Ming replied.

Jin Dafu spoke with a tone of frustration at wasted potential: "I really don't get it. Yang Ping has already won a Nobel Prize, achieved fame and success, got whatever he wants! Why suffer through all this? He could leverage his youth and fame to make more money and enjoy life; instead, he's grinding away for nothing!"

Next chapter will be updated first on this website. Come back and continue reading tomorrow, everyone!

If you find any errors ( broken links, non-standard content, etc.. ), Please let us know < report chapter > so we can fix it as soon as possible.